rs17036350
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_004958.4(MTOR):c.7367-1440G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0827 in 455,678 control chromosomes in the GnomAD database, including 2,895 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.097 ( 1205 hom., cov: 31)
Exomes 𝑓: 0.076 ( 1690 hom. )
Consequence
MTOR
NM_004958.4 intron
NM_004958.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.745
Publications
17 publications found
Genes affected
MTOR (HGNC:3942): (mechanistic target of rapamycin kinase) The protein encoded by this gene belongs to a family of phosphatidylinositol kinase-related kinases. These kinases mediate cellular responses to stresses such as DNA damage and nutrient deprivation. This kinase is a component of two distinct complexes, mTORC1, which controls protein synthesis, cell growth and proliferation, and mTORC2, which is a regulator of the actin cytoskeleton, and promotes cell survival and cell cycle progression. This protein acts as the target for the cell-cycle arrest and immunosuppressive effects of the FKBP12-rapamycin complex. Inhibitors of mTOR are used in organ transplants as immunosuppressants, and are being evaluated for their therapeutic potential in SARS-CoV-2 infections. Mutations in this gene are associated with Smith-Kingsmore syndrome and somatic focal cortical dysplasia type II. The ANGPTL7 gene is located in an intron of this gene. [provided by RefSeq, Aug 2020]
MTOR Gene-Disease associations (from GenCC):
- macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Illumina, Orphanet, Labcorp Genetics (formerly Invitae), G2P
- overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genesInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.198 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| MTOR | NM_004958.4 | c.7367-1440G>A | intron_variant | Intron 54 of 57 | ENST00000361445.9 | NP_004949.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| MTOR | ENST00000361445.9 | c.7367-1440G>A | intron_variant | Intron 54 of 57 | 1 | NM_004958.4 | ENSP00000354558.4 |
Frequencies
GnomAD3 genomes AF: 0.0967 AC: 14692AN: 151990Hom.: 1194 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
14692
AN:
151990
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0951 AC: 12157AN: 127806 AF XY: 0.0948 show subpopulations
GnomAD2 exomes
AF:
AC:
12157
AN:
127806
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0756 AC: 22949AN: 303570Hom.: 1690 Cov.: 0 AF XY: 0.0824 AC XY: 14239AN XY: 172882 show subpopulations
GnomAD4 exome
AF:
AC:
22949
AN:
303570
Hom.:
Cov.:
0
AF XY:
AC XY:
14239
AN XY:
172882
show subpopulations
African (AFR)
AF:
AC:
1670
AN:
8588
American (AMR)
AF:
AC:
3822
AN:
27242
Ashkenazi Jewish (ASJ)
AF:
AC:
861
AN:
10784
East Asian (EAS)
AF:
AC:
1139
AN:
9194
South Asian (SAS)
AF:
AC:
10247
AN:
59706
European-Finnish (FIN)
AF:
AC:
658
AN:
12364
Middle Eastern (MID)
AF:
AC:
146
AN:
2776
European-Non Finnish (NFE)
AF:
AC:
3371
AN:
158706
Other (OTH)
AF:
AC:
1035
AN:
14210
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
981
1962
2944
3925
4906
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
158
316
474
632
790
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0969 AC: 14742AN: 152108Hom.: 1205 Cov.: 31 AF XY: 0.102 AC XY: 7556AN XY: 74370 show subpopulations
GnomAD4 genome
AF:
AC:
14742
AN:
152108
Hom.:
Cov.:
31
AF XY:
AC XY:
7556
AN XY:
74370
show subpopulations
African (AFR)
AF:
AC:
8368
AN:
41472
American (AMR)
AF:
AC:
2067
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
AC:
240
AN:
3470
East Asian (EAS)
AF:
AC:
676
AN:
5172
South Asian (SAS)
AF:
AC:
955
AN:
4826
European-Finnish (FIN)
AF:
AC:
567
AN:
10594
Middle Eastern (MID)
AF:
AC:
19
AN:
294
European-Non Finnish (NFE)
AF:
AC:
1620
AN:
67998
Other (OTH)
AF:
AC:
208
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
630
1260
1890
2520
3150
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
158
316
474
632
790
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
631
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.